Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02756962
Title Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Washington University School of Medicine
Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST